Medpace Holdings, Inc. (MEDP)
620.10
-0.66
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
620.10
0.00 (0.00%)
After-Hours: 20:00
Medpace Holdings Debt to Equity Ratio : 0.3322 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3322 |
| March 31, 2026 | 0.2442 |
| December 31, 2025 | 0.2981 |
| September 30, 2025 | 0.4903 |
| June 30, 2025 | 0.8693 |
| March 31, 2025 | 0.2533 |
| December 31, 2024 | 0.1811 |
| September 30, 2024 | 0.1723 |
| June 30, 2024 | 0.2013 |
| March 31, 2024 | 0.2355 |
| December 31, 2023 | 0.2943 |
| September 30, 2023 | 0.3468 |
| June 30, 2023 | 0.5482 |
| March 31, 2023 | 0.7975 |
| December 31, 2022 | 0.5387 |
| September 30, 2022 | 0.8505 |
| June 30, 2022 | 1.424 |
| March 31, 2022 | 0.2646 |
| December 31, 2021 | 0.1545 |
| September 30, 2021 | 0.1594 |
| June 30, 2021 | 0.1503 |
| March 31, 2021 | 0.1516 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.1626 |
| September 30, 2020 | 0.1589 |
| June 30, 2020 | 0.1747 |
| March 31, 2020 | 0.0891 |
| December 31, 2019 | 0.0774 |
| September 30, 2019 | 0.0813 |
| June 30, 2019 | 0.0818 |
| March 31, 2019 | 0.1791 |
| December 31, 2018 | 0.1803 |
| September 30, 2018 | 0.2471 |
| June 30, 2018 | 0.3501 |
| March 31, 2018 | 0.4376 |
| December 31, 2017 | 0.4929 |
| September 30, 2017 | 0.3848 |
| June 30, 2017 | 0.305 |
| March 31, 2017 | 0.3039 |
| December 31, 2016 | 0.3147 |
| September 30, 2016 | 0.3007 |
| June 30, 2016 | 0.931 |
| March 31, 2016 | 0.9771 |
| December 31, 2015 | 0.9871 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| IQVIA Holdings, Inc. | 2.632 |
| Charles River Laboratories International, Inc. | 1.069 |
| Avantor, Inc. | 0.6568 |
| Champions Oncology, Inc. | 1.167 |
| Personalis, Inc. | 0.1616 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.057B |
| Total Liabilities (Quarterly) | 1.623B |
| Shareholders Equity (Quarterly) | 433.86M |
| Current Ratio | 0.7317 |
| Net Debt Paydown Yield | 0.01% |